Inhibiting Alternative Pathway Complement Activation by Targeting the Factor D Exosite
Open Access
- 1 April 2012
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (16) , 12886-12892
- https://doi.org/10.1074/jbc.m112.345082
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Diversity in the C3b Convertase Contact Residues and Tertiary Structures of the Staphylococcal Complement Inhibitor (SCIN) Protein FamilyJournal of Biological Chemistry, 2012
- Allosteric inhibition of complement function by a staphylococcal immune evasion proteinProceedings of the National Academy of Sciences, 2010
- Genetic control of the alternative pathway of complement in humans and age-related macular degenerationHuman Molecular Genetics, 2009
- Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitorNature Immunology, 2009
- Structural and Functional Analysis of a C3b-specific Antibody That Selectively Inhibits the Alternative Pathway of ComplementJournal of Biological Chemistry, 2009
- Structural insight into distinct mechanisms of protease inhibition by antibodiesProceedings of the National Academy of Sciences, 2007
- Complement-targeted therapeuticsNature Biotechnology, 2007
- Inference of Macromolecular Assemblies from Crystalline StateJournal of Molecular Biology, 2007
- The Structure of OMCI, a Novel Lipocalin Inhibitor of the Complement SystemJournal of Molecular Biology, 2007
- The Mechanism of Inhibition of Antibody-based Inhibitors of Membrane-type Serine Protease 1 (MT-SP1)Journal of Molecular Biology, 2007